Jiangsu Traumark Medical Instrument Co., Ltd. was founded in April 2014 with registered capital of 250 million RMB. The company is located by Lake Taihu in Changzhou. The plant area is 30000㎡, the production site is 2000㎡ including 1000㎡ one-million-level grade purification workshop.

Traumark Medical is committed to researching, manufacturing and commercializing of highly differentiated advanced wound care and home care & first aid products for health care professionals and patients with reasonable price and outstanding services.

Traumark Medical is committed to developing and manufacturing advanced wound care products and continually enhancing the product line towards diversified healing solutions.

At Traumark it is our enduring mission to bring solutions that help heal your patient.

  • 2015

    May.  Traumark Medical completes FDA establishment registration.

    Jan.  Traumark Medical acquires ISO13485 certification.

  • 2014

    Apr.  Jiangsu Traumark Medical Instrument Co., Ltd. is founded based on AWC project and joins Flon Holdings Group.

  • 2013

    Apr.  Trauson Holdings is acquired by Stryker. The AWC team joins Wound Care Division of Jiangsu Trausim Medical Instrument Co., Ltd.

  • 2012

    Apr.  Advanced Wound Care Project is founded and operated by an independent team in Trauson Holdings Co., Ltd.

Traumark Medical adheres to the pursuit of product quality, focus on and meets the consumers’ needs.

Traumark Medical believes our employees are the most valuable asset. We create career training and other opportunities for their future development.

Traumark Medical is committed to participating in social welfare activities, maintain a high level of consciousness of social responsibility.

  • 2014-08-08
    [Charity Donation]A explosion accident happened in Kunshan,Jiangsu Province.
    >more


    Over 150 people were injured in this accident and more of them suffered level 3 burn. Some of the patients were transferred to hospitals in Changzhou for medical care. Traumark medical donated its products to the Red Cross Charity for the treatment of the wounded at the first time.